rupiya.io
⠋Loading sector...
0%
❯ Analyzing sector P/E ratios...
Specialty exposure and domestic chronic therapy share remain the main margin moats in Indian pharma.
| Company | M.Cap | Price | P/E | P/B | ROE | ROCE | D/E | Div Yield | 1Y Return |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹4,51,075 Cr | ₹1,903.4 | 41.3 | 5.8 | 0.0% | 25.1% | 0.1 | 0.9% | +7.16% |
| Dr Reddys Laboratories Ltd | ₹1,11,310 Cr | ₹1,354.6 | 19.7 | 3.0 | 11.8% | 20.7% | 0.2 | 0.6% | +8.69% |
| Cipla Ltd | ₹1,15,638 Cr | ₹1,451.8 | 25.5 | 3.5 | 11.7% | 24.0% | 0.0 | 0.9% | -2.61% |
| Apollo Hospitals Enterprise Ltd | ₹1,16,201 Cr | ₹8,837 | 64.5 | 12.8 | 0.0% | 25.7% | 0.8 | 0.3% | +24.63% |
| Divis Laboratories Ltd | ₹1,79,486 Cr | ₹6,771.5 | 72.5 | 11.6 | 0.0% | 19.7% | 0.0 | 0.0% | +7.59% |
| Torrent Pharmaceuticals Ltd | ₹1,49,446 Cr | ₹4,856.7 | 69.7 | 17.7 | 0.0% | 28.6% | 0.3 | 0.8% | +29.06% |
| Max Healthcare Institute Ltd | ₹1,02,191 Cr | ₹1,118.4 | 72.5 | 10.2 | 0.0% | 24.5% | 0.3 | 0.0% | +4.02% |
| Zydus Lifesciences Ltd | ₹1,01,755 Cr | ₹1,153 | 20.6 | 4.0 | 0.0% | 22.1% | 0.3 | 0.0% | +25.34% |
| 3B BlackBio Dx Ltd | ₹1,178 Cr | ₹1,168.5 | 0.0 | 3.9 | 533.3% | 0.0% | 0.0 | 0.0% | -22.51% |
| Aarey Drugs & Pharmaceuticals Ltd | ₹258 Cr | ₹87.99 | 74.6 | 1.7 | 0.0% | 0.7% | 0.4 | 0.0% | +13.25% |
| Aarti Drugs Ltd | ₹3,340 Cr | ₹388.95 | 16.6 | 2.5 | 13.4% | 12.5% | 0.4 | 0.0% | -4.30% |
| Aarti Pharmalabs Ltd | ₹6,358 Cr | ₹699.5 | 29.8 | 3.1 | 0.0% | 21.2% | 0.3 | 0.6% | +0.93% |
| Abbott India Ltd | ₹58,659 Cr | ₹26,725 | 37.9 | 12.3 | 34.5% | 57.1% | 0.0 | 0.0% | -6.15% |
| Anlon Healthcare Ltd | ₹716 Cr | ₹15.62 | 20.7 | 2.6 | 0.0% | 24.2% | 0.3 | 0.0% | +5.73% |
| Ajanta Pharma Ltd | ₹39,663 Cr | ₹3,314.5 | 39.1 | 9.2 | 25.4% | 59.9% | 0.1 | 0.9% | +24.57% |
| Akums Drugs and Pharmaceuticals Ltd | ₹7,957 Cr | ₹649.85 | 31.2 | 2.4 | 8.0% | 16.8% | 0.1 | 0.0% | +48.88% |
| Albert David Ltd-$ | ₹409 Cr | ₹705.05 | 42.5 | 1.0 | -0.4% | -1.1% | 0.1 | 0.7% | -6.68% |
| Alivus Life Sciences Ltd | ₹12,953 Cr | ₹1,144.7 | 23.0 | 3.9 | 18.4% | 34.9% | 0.0 | 0.0% | +30.26% |
| Alkem Laboratories Ltd | ₹65,211 Cr | ₹5,667.5 | 27.5 | 4.9 | 0.0% | 19.7% | 0.2 | 0.9% | +1.21% |
| Alpa Laboratories Ltd | ₹148 Cr | ₹68.36 | 12.7 | 0.9 | 0.0% | 3.0% | 0.0 | 0.0% | -13.67% |
| Amanta Healthcare Ltd | ₹504 Cr | ₹179.8 | 36.9 | 2.1 | 0.0% | 16.6% | 0.9 | 0.0% | +79.35% |
| Ambalal Sarabhai Enterprises Ltd | ₹0 Cr | ₹31.96 | 24.0 | 1.8 | 0.0% | 7.7% | 0.3 | 0.0% | -11.61% |
| Amrutanjan Health Care Ltd-$ | ₹1,613 Cr | ₹538.05 | 28.3 | 4.4 | 0.0% | 27.1% | 0.0 | 0.0% | -18.66% |
| Anthem Biosciences Ltd | ₹44,010 Cr | ₹766.65 | 91.7 | 16.0 | 0.0% | 32.3% | 0.0 | 0.0% | +16.41% |
| Anuh Pharma Ltd | ₹799 Cr | ₹78.93 | 19.1 | 2.4 | 0.0% | 28.3% | 0.0 | 0.0% | +0.61% |
| Alembic Pharmaceuticals Ltd | ₹14,165 Cr | ₹829.35 | 22.5 | 2.5 | 12.4% | 13.1% | 0.3 | 0.0% | -6.48% |
| Aster DM Healthcare Ltd | ₹38,964 Cr | ₹789.15 | 117.6 | 8.6 | 0.0% | 23.9% | 0.4 | 0.0% | +26.63% |
| AstraZeneca Pharma India Ltd | ₹21,362 Cr | ₹8,204 | 106.2 | 26.7 | 0.0% | 156.4% | 0.0 | 0.0% | -9.06% |
| Aurobindo Pharma Ltd | ₹87,910 Cr | ₹1,583.1 | 25.7 | 2.5 | 0.0% | 15.3% | 0.2 | 0.0% | +34.54% |
| Bafna Pharmaceuticals Ltd | ₹319 Cr | ₹207.89 | 32.9 | 3.5 | 0.0% | 131.3% | 0.4 | 0.0% | +40.31% |
| Bajaj Healthcare Ltd | ₹971 Cr | ₹331.55 | 42.8 | 1.7 | 4.3% | 10.2% | 0.5 | 0.6% | -20.22% |
| BALAXI | ₹143 Cr | ₹23.85 | 15.1 | 0.6 | 0.0% | 19.3% | 0.2 | 0.0% | -51.67% |
| Bal Pharma Ltd | ₹126 Cr | ₹79.17 | 15.5 | 1.6 | 0.0% | 10.4% | 2.0 | 0.0% | +10.77% |
| BETA | ₹1,284 Cr | ₹2,069.1 | 19.9 | 2.9 | 0.0% | 37.7% | 0.7 | 0.0% | +14.61% |
| Biocon Ltd | ₹68,635 Cr | ₹406.9 | 149.2 | 2.0 | 1.2% | 4.7% | 0.4 | 0.1% | +6.06% |
| Biofil Chemicals & Pharmaceuticals Ltd | ₹52 Cr | ₹33.58 | 19.0 | 2.5 | 0.0% | 0.0% | 0.0 | 0.0% | +0.48% |
| Bliss GVS Pharma Ltd | ₹3,040 Cr | ₹511.8 | 28.2 | 2.7 | 0.0% | 9.4% | 0.0 | 0.0% | +215.56% |
| Blue Jet Healthcare Ltd | ₹7,304 Cr | ₹579.15 | 24.9 | 5.8 | 0.0% | 32.1% | 0.0 | 0.0% | +5.78% |
| Brooks Laboratories Ltd | ₹138 Cr | ₹73.03 | 6.4 | 1.2 | 0.0% | 0.0% | 0.1 | 0.0% | -23.21% |
| Caplin Point Laboratories Ltd | ₹15,116 Cr | ₹2,566.8 | 23.6 | 4.9 | 0.0% | 32.5% | 0.0 | 0.0% | +33.19% |
| Cohance Lifesciences Ltd | ₹16,225 Cr | ₹442.35 | 90.2 | 4.3 | 0.0% | 20.5% | 0.1 | 0.0% | -16.57% |
| Concord Biotech Ltd | ₹11,771 Cr | ₹1,272.6 | 37.8 | 6.5 | 0.0% | 27.2% | 0.0 | 0.0% | -8.54% |
| Corona Remedies Ltd | ₹10,881 Cr | ₹1,988.8 | 60.3 | 16.9 | 27.4% | 31.4% | 0.2 | 0.4% | +38.26% |
| Dishman Carbogen Amcis Ltd | ₹2,939 Cr | ₹197.64 | 24.7 | 0.5 | 0.0% | 6.2% | 0.4 | 0.0% | -11.14% |
| Dr Agarwals Eye Hospital Ltd-$ | ₹2,452 Cr | ₹4,996 | 34.4 | 7.6 | 27.0% | 0.0% | 1.1 | 0.1% | +11.71% |
| Emcure Pharmaceuticals Ltd | ₹31,864 Cr | ₹1,843.5 | 34.5 | 6.4 | 19.6% | 21.7% | 0.3 | 0.2% | +33.25% |
| Entero Healthcare Solutions Ltd | ₹5,186 Cr | ₹1,210.1 | 46.1 | 2.9 | 0.0% | 54.0% | 0.3 | 0.0% | +21.11% |
| Eris Lifesciences Ltd | ₹18,641 Cr | ₹1,435.1 | 42.7 | 5.9 | 0.0% | 13.8% | 0.7 | 0.0% | -6.44% |
| FDC Ltd | ₹5,892 Cr | ₹426.15 | 27.2 | 2.4 | 0.0% | 14.1% | 0.0 | 1.4% | +2.69% |
| Fermenta Biotech Ltd | ₹847 Cr | ₹368.6 | 10.0 | 2.2 | 22.7% | 0.0% | 0.3 | 0.0% | +4.83% |
| Fortis Healthcare Ltd | ₹71,536 Cr | ₹971.9 | 74.5 | 7.6 | 0.0% | 31.9% | 0.3 | 0.0% | +12.51% |
| Gaudium IVF and Women Health Ltd | ₹783 Cr | ₹119.48 | 32.3 | 14.3 | 0.0% | 45.5% | 0.0 | 0.0% | 0.00% |
| Gujarat Kidney and Super Speciality Ltd | ₹1,082 Cr | ₹128.94 | 63.3 | 30.1 | 0.0% | 39.4% | 0.0 | 0.0% | +22.68% |
| Gland Pharma Ltd | ₹35,212 Cr | ₹2,550 | 41.6 | 3.7 | 10.5% | 18.1% | 0.0 | 0.0% | +49.74% |
| GlaxoSmithKline Pharmaceuticals Ltd | ₹41,331 Cr | ₹2,406.5 | 43.3 | 24.2 | 0.0% | 159.4% | 0.0 | 0.0% | -5.97% |
| Glenmark Pharmaceuticals Ltd | ₹65,059 Cr | ₹2,264.9 | 61.2 | 6.8 | 0.0% | 19.4% | 0.1 | 0.0% | +16.84% |
| GPT Healthcare Ltd | ₹1,163 Cr | ₹156.22 | 28.7 | 4.6 | 0.0% | 32.8% | 0.4 | 1.8% | +10.48% |
| Granules India Ltd-$ | ₹18,041 Cr | ₹863.55 | 29.8 | 3.5 | 13.5% | 15.6% | 0.3 | 0.2% | +58.62% |
| Gufic Biosciences Ltd | ₹2,779 Cr | ₹380.4 | 55.5 | 4.4 | 0.0% | 15.6% | 0.6 | 0.0% | +8.61% |
| Gujarat Themis Biosyn Ltd | ₹3,793 Cr | ₹377.25 | 78.8 | 14.3 | 0.0% | 24.1% | 0.3 | 0.0% | +1.95% |
| Haleos Labs Ltd | ₹471 Cr | ₹1,612.3 | 23.7 | 2.3 | 0.0% | 14.9% | 0.3 | 0.0% | +21.91% |
| HealthCare Global Enterprises Ltd | ₹9,440 Cr | ₹647.65 | 471.8 | 9.6 | 0.0% | 14.0% | 1.8 | 0.0% | -7.27% |
| Health X Platform Ltd | ₹954 Cr | ₹315.6 | 36.6 | 1.4 | 0.0% | -16.7% | 0.0 | 0.0% | +7.22% |
| Hester Biosciences Ltd | ₹1,560 Cr | ₹2,205.6 | 37.9 | 4.7 | 0.0% | 10.0% | 0.6 | 0.0% | +35.4% |
| Hikal Ltd | ₹2,513 Cr | ₹217.4 | 0.0 | 2.0 | 0.0% | 11.2% | 0.0 | 0.0% | -5.93% |
| Indoco Remedies Ltd | ₹2,074 Cr | ₹240.62 | 0.0 | 1.8 | -10.1% | -1.6% | 1.2 | 0.1% | -6.40% |
| Indraprastha Medical Corporation Ltd | ₹3,301 Cr | ₹378.85 | 18.1 | 5.0 | 0.0% | 39.0% | 0.1 | 0.0% | -16.02% |
| Ind-Swift Laboratories Ltd | ₹1,163 Cr | ₹215.15 | 3.9 | 0.8 | 0.0% | 0.0% | 0.0 | 0.0% | +142.74% |
| Innova Captab Ltd | ₹5,019 Cr | ₹968.1 | 35.6 | 4.9 | 0.0% | 19.9% | 0.3 | 0.0% | +44.96% |
| IOL Chemicals & Pharmaceuticals Ltd | ₹3,183 Cr | ₹165.04 | 27.5 | 1.8 | 0.0% | 8.7% | 0.1 | 0.9% | +75.61% |
| Ipca Laboratories Ltd | ₹40,739 Cr | ₹1,793.1 | 44.8 | 5.0 | 0.0% | 20.1% | 0.1 | 0.1% | +23.7% |
| Jagsonpal Pharmaceuticals Ltd | ₹1,386 Cr | ₹238.72 | 32.7 | 5.2 | 16.7% | 17.7% | 0.0 | 1.9% | +18.94% |
| JB Chemicals & Pharmaceuticals Ltd | ₹34,337 Cr | ₹2,422 | 48.0 | 8.8 | 0.0% | 29.8% | 0.0 | 0.9% | +34.63% |
| Jupiter Life Line Hospitals Ltd | ₹8,773 Cr | ₹1,461 | 46.5 | 6.0 | 13.4% | 37.7% | 0.4 | 0.0% | +2.60% |
| Jeena Sikho Lifecare Ltd | ₹7,848 Cr | ₹570.4 | 37.0 | 22.2 | 0.0% | 57.3% | 0.3 | 0.0% | -16.44% |
| Jubilant Pharmova Ltd | ₹16,043 Cr | ₹978.8 | 37.2 | 2.4 | 0.0% | 11.6% | 0.4 | 0.0% | -5.73% |
| Kilitch Drugs India Ltd | ₹610 Cr | ₹185.44 | 22.2 | 2.2 | 12.4% | 17.2% | 0.3 | 0.0% | +12.2% |
| Krishna Institute of Medical Sciences Ltd | ₹28,970 Cr | ₹805.65 | 96.0 | 12.8 | 9.7% | 17.1% | 1.7 | 0.0% | +18.97% |
| Kopran Ltd | ₹832 Cr | ₹189.39 | 50.4 | 1.7 | 0.0% | 16.0% | 0.3 | 0.0% | +47.89% |
| Kovai Medical Center & Hospital Ltd | ₹5,868 Cr | ₹6,036.5 | 24.9 | 4.9 | 0.0% | 20.2% | 0.3 | 0.0% | -3.38% |
| Kwality Pharmaceuticals Ltd | ₹1,784 Cr | ₹2,550.5 | 31.5 | 6.2 | 15.8% | 0.0% | 0.4 | 0.0% | +130.14% |
| Krebs Biochemicals & Industries Ltd-$ | ₹125 Cr | ₹58.18 | 0.0 | -0.8 | 0.0% | 0.0% | 0.0 | 0.0% | -10.15% |
| Lasa Supergenerics Ltd | ₹41 Cr | ₹7.3 | 2.2 | 0.7 | 0.0% | -7.1% | 0.1 | 0.0% | -25.56% |
| Laurus Labs Ltd | ₹70,884 Cr | ₹1,477.4 | 84.0 | 14.8 | 17.7% | 9.8% | 0.5 | 0.0% | +44.64% |
| Lincoln Pharmaceuticals Ltd | ₹1,292 Cr | ₹619.65 | 14.7 | 1.8 | 0.0% | 15.1% | 0.0 | 0.0% | +24.74% |
| Lotus Eye Hospital And Institute Ltd | ₹223 Cr | ₹123.23 | 334.4 | 3.4 | 0.0% | 1.5% | 0.1 | 0.0% | +16.13% |
| Lupin Ltd | ₹1,03,910 Cr | ₹2,490.2 | 24.1 | 5.3 | 26.9% | 24.6% | 0.3 | 0.8% | +21.37% |
| Lyka Labs Ltd | ₹219 Cr | ₹70.85 | 104.2 | 2.2 | 0.0% | 0.0% | 0.0 | 0.0% | -8.95% |
| Mangalam Drugs & Organics Ltd | ₹48 Cr | ₹27.91 | 0.0 | 0.4 | 0.0% | 8.6% | 0.8 | 0.0% | +13.52% |
| Mankind Pharma Ltd | ₹1,03,368 Cr | ₹2,527.4 | 58.1 | 6.8 | 0.0% | 12.6% | 0.5 | 0.0% | +15.65% |
| Marksans Pharma Ltd | ₹9,862 Cr | ₹261.2 | 27.4 | 3.7 | 0.0% | 35.2% | 0.1 | 0.0% | +37.39% |
| Max India Ltd | ₹823 Cr | ₹156.62 | 0.0 | 1.8 | 0.0% | 0.0% | 0.4 | 0.0% | -18.42% |
| Global Health Ltd | ₹33,168 Cr | ₹1,324.3 | 59.8 | 9.0 | 15.0% | 26.4% | 0.3 | 0.0% | +14.26% |
| Medi Assist Healthcare Services Ltd | ₹2,786 Cr | ₹357.1 | 47.5 | 4.5 | 12.7% | 19.1% | 0.1 | 0.5% | -22.56% |
| Medicamen Biotech Ltd-$ | ₹380 Cr | ₹246.85 | 48.1 | 1.7 | 0.0% | 8.9% | 0.1 | 0.0% | -29.78% |
| Medico Remedies Ltd | ₹365 Cr | ₹39.75 | 31.4 | 5.5 | 0.0% | 16.5% | 0.2 | 0.0% | -23.23% |
| Medplus Health Services Ltd | ₹11,136 Cr | ₹816.65 | 53.9 | 6.0 | 0.0% | 16.0% | 0.7 | 0.0% | +0.81% |
| Morepen Laboratories Ltd | ₹2,299 Cr | ₹61.19 | 23.4 | 1.9 | 0.0% | 24.5% | 0.1 | 0.0% | +48.86% |
| Natural Capsules Ltd | ₹159 Cr | ₹147.26 | 0.0 | 0.7 | 0.0% | 4.7% | 0.5 | 0.0% | -17.81% |
| Natco Pharma Ltd | ₹21,019 Cr | ₹984.15 | 13.5 | 2.4 | 0.0% | 30.8% | 0.0 | 0.4% | +10.23% |
| Nectar Lifesciences Ltd | ₹245 Cr | ₹11.22 | 0.0 | 0.4 | 0.0% | -7.6% | 0.6 | 0.0% | -43.89% |
| Nephrocare Health Services Ltd | ₹6,459 Cr | ₹659.55 | 90.9 | 1.7 | 0.0% | 96.0% | 0.4 | 0.0% | +39.96% |
| Neuland Laboratories Ltd | ₹21,003 Cr | ₹18,900 | 57.7 | 11.2 | 0.0% | 25.8% | 0.2 | 0.0% | +13.35% |
| NGL Fine Chem Ltd | ₹1,450 Cr | ₹3,092.3 | 41.0 | 4.8 | 0.0% | 6.3% | 0.3 | 0.0% | +146.17% |
| Narayana Hrudayalaya Ltd | ₹37,287 Cr | ₹2,002.5 | 48.0 | 9.2 | 0.0% | 20.9% | 0.6 | 0.0% | +5.99% |
| Novartis India Ltd | ₹2,917 Cr | ₹1,457.8 | 30.0 | 3.8 | 0.0% | 12.8% | 0.0 | 0.0% | +46.36% |
| Onesource Specialty Pharma Ltd | ₹21,183 Cr | ₹1,626.8 | 0.0 | 3.6 | 0.0% | 0.0% | 0.2 | 0.0% | -1.86% |
| Orchid Pharma Ltd | ₹3,617 Cr | ₹924.65 | 188.6 | 2.9 | 0.0% | 0.0% | 0.0 | 0.0% | +10.68% |
| Ortin Global Ltd | ₹11 Cr | ₹17.09 | 0.0 | 8.6 | 0.0% | -74.4% | 0.7 | 0.0% | +39.8% |
| Panacea Biotec Ltd | ₹2,370 Cr | ₹538.4 | 0.0 | 2.9 | 0.0% | -7.7% | 0.0 | 0.0% | +63.46% |
| PAR | ₹107 Cr | ₹91.49 | 7.7 | 1.0 | 0.0% | 25.9% | 0.0 | 0.0% | -5.32% |
| Park Medi World Ltd | ₹10,356 Cr | ₹285.35 | 34.9 | 4.7 | 16.9% | 20.5% | 0.2 | 0.0% | +76.14% |
| Pfizer Ltd | ₹22,262 Cr | ₹4,538.7 | 30.8 | 5.8 | 17.2% | 32.5% | 0.0 | 1.5% | -8.62% |
| Procter & Gamble Health Ltd | ₹8,723 Cr | ₹6,250.5 | 36.9 | 14.1 | 0.0% | 0.0% | 0.0 | 0.0% | +10.84% |
| Piramal Pharma Ltd | ₹23,064 Cr | ₹175.23 | 0.0 | 2.9 | -4.0% | 0.7% | 0.7 | 0.0% | +1.09% |
| Rainbow Children's Medicare Ltd | ₹13,708 Cr | ₹1,422 | 53.5 | 9.0 | 0.0% | 19.8% | 0.5 | 0.0% | +5.72% |
| RPG Life Sciences Ltd | ₹3,805 Cr | ₹2,440.3 | 18.8 | 6.3 | 20.3% | 30.6% | 0.0 | 1.1% | +7.85% |
| Rubicon Research Ltd | ₹15,832 Cr | ₹1,379.6 | 76.9 | 22.9 | 16.8% | 0.0% | 87.7 | 0.0% | +124.25% |
| Sai Parenterals Ltd | ₹0 Cr | ₹598.55 | 108.6 | 8.6 | 16.8% | 10.3% | 0.4 | 0.0% | 0.00% |
| SAKAR | ₹1,529 Cr | ₹823.35 | 61.1 | 5.1 | 10.0% | 14.2% | 0.2 | 0.0% | +142.44% |
| Sanofi India Ltd | ₹7,363 Cr | ₹3,461.9 | 23.8 | 9.8 | 0.0% | 413.1% | 0.0 | 0.0% | -18.97% |
| Sanofi Consumer Healthcare India Ltd | ₹11,059 Cr | ₹4,603.1 | 42.8 | 28.8 | 0.0% | 874.4% | 0.1 | 0.0% | -0.83% |
| Senores Pharmaceuticals Ltd | ₹5,202 Cr | ₹1,358.8 | 43.9 | 6.9 | 13.8% | 21.1% | 0.4 | 0.0% | +76.3% |
| Shalby Ltd | ₹1,690 Cr | ₹173.01 | 204.6 | 1.7 | 0.0% | 7.9% | 0.5 | 0.0% | -11.31% |
| Shilpa Medicare Ltd | ₹9,314 Cr | ₹599.8 | 42.2 | 3.8 | 0.0% | 12.0% | 0.2 | 0.0% | +79.72% |
| Sigachi Industries Ltd | ₹779 Cr | ₹21.81 | 0.0 | 1.5 | 0.0% | 21.4% | 0.3 | 0.0% | -34.46% |
| SMS Pharmaceuticals Ltd | ₹3,727 Cr | ₹423.5 | 39.8 | 4.9 | 0.0% | 15.9% | 0.4 | 0.0% | +31.44% |
| Solara Active Pharma Sciences Ltd | ₹2,704 Cr | ₹560.35 | 0.0 | 1.9 | -0.6% | 21.6% | 0.6 | 0.0% | +1.57% |
| Sun Pharma Advanced Research Company Ltd | ₹5,265 Cr | ₹266.34 | 0.0 | -15.3 | 0.0% | 0.0% | 0.0 | 0.0% | +87.31% |
| Strides Pharma Science Ltd | ₹10,613 Cr | ₹1,128.2 | 20.8 | 3.9 | 0.0% | 25.0% | 0.7 | 0.0% | +26.59% |
| Sudeep Pharma Ltd | ₹7,333 Cr | ₹810.95 | 43.7 | 9.8 | 0.0% | 30.5% | 0.2 | 0.0% | +21.02% |
| Supriya Lifescience Ltd | ₹5,505 Cr | ₹842.4 | 29.7 | 5.1 | 0.0% | 32.4% | 0.0 | 0.0% | +16.87% |
| Suven Life Sciences Ltd | ₹6,661 Cr | ₹319.35 | 0.0 | 20.0 | -78.8% | 0.0% | 0.0 | 0.0% | +89.76% |
| Syncom Formulations India Ltd-$ | ₹1,283 Cr | ₹13.89 | 18.7 | 3.3 | 0.0% | 21.5% | 0.0 | 0.0% | -5.99% |
| Take Solutions Ltd | ₹372 Cr | ₹24.78 | 0.0 | 14.5 | 0.0% | 0.0% | 0.0 | 0.0% | -29.4% |
| Themis Medicare Ltd | ₹912 Cr | ₹116.78 | 0.0 | 2.4 | 0.0% | 11.4% | 0.3 | 0.0% | +19.3% |
| TTK Healthcare Ltd | ₹1,267 Cr | ₹931.1 | 21.1 | 1.2 | 0.0% | 2.8% | 0.0 | 0.0% | -11.91% |
| Unichem Laboratories Ltd | ₹2,628 Cr | ₹477.25 | 8.9 | 1.1 | 0.0% | 4.9% | 0.2 | 0.0% | +5.40% |
| VAISHALI | ₹92 Cr | ₹7.44 | 117.8 | 1.4 | 0.0% | 11.3% | 0.2 | 0.0% | -35.11% |
| Valiant Laboratories Ltd | ₹408 Cr | ₹64.23 | 0.0 | 1.2 | -1.2% | -1.7% | 0.2 | 0.0% | -9.10% |
| Venus Remedies Ltd | ₹1,220 Cr | ₹1,736.1 | 16.0 | 2.1 | 0.0% | 23.7% | 0.0 | 0.0% | +123.28% |
| Vivimed Labs Ltd | ₹54 Cr | ₹5.59 | 0.0 | -1.1 | 0.0% | -41.5% | 0.0 | 0.0% | +15.15% |
| Viyash Scientific Ltd | ₹9,841 Cr | ₹278.9 | 87.4 | 7.0 | 0.0% | 20.0% | 0.6 | 0.0% | +30.72% |
| Wanbury Ltd | ₹902 Cr | ₹278.85 | 13.5 | 14.3 | 0.0% | 72.2% | 0.0 | 0.0% | +19.96% |
| Windlas Biotech Ltd | ₹1,647 Cr | ₹853.95 | 24.8 | 3.1 | 0.0% | 21.0% | 0.1 | 0.0% | +13.9% |
| Wockhardt Ltd | ₹25,463 Cr | ₹1,857.4 | 119.3 | 5.6 | 4.0% | 5.8% | 0.4 | 0.0% | +40.51% |
| Yatharth Hospital & Trauma Care Services Ltd | ₹7,790 Cr | ₹827 | 46.6 | 4.6 | 0.0% | 63.4% | 0.0 | 0.0% | +17.65% |
| Zim Laboratories Ltd | ₹530 Cr | ₹120.7 | 68.7 | 1.9 | 0.0% | 8.0% | 0.5 | 0.0% | +71.8% |
| ZOTA | ₹3,664 Cr | ₹1,401.7 | 0.0 | 11.7 | 0.0% | -32.7% | 0.6 | 0.0% | +18.43% |
| Tejnaksh Healthcare Ltd | ₹31 Cr | ₹14.99 | 22.1 | 1.2 | 8.3% | 0.0% | 0.0 | 0.0% | -30.73% |
| Hamps Bio Ltd | ₹23 Cr | ₹26.25 | 0.0 | 2.8 | 0.0% | 0.0% | 0.0 | 0.0% | -48.4% |
| Muller & Phipps India Ltd | ₹15 Cr | ₹211.85 | 0.0 | -10.3 | -100.0% | 0.0% | 0.0 | 0.0% | -41.14% |
| Syschem India Ltd | ₹236 Cr | ₹42 | 32.5 | 2.2 | 0.0% | 0.0% | 0.0 | 0.0% | +2.54% |
| Vivo Bio Tech Ltd | ₹61 Cr | ₹23.7 | 12.0 | 0.6 | 15.2% | 0.0% | 0.0 | 0.0% | -38.73% |
| Veerhealth Care Ltd | ₹45 Cr | ₹32.48 | 56.1 | 1.9 | 0.0% | 0.0% | 0.0 | 0.0% | +146.25% |
| Amwill Health Care Ltd | ₹65 Cr | ₹44 | 8.0 | 0.9 | 34.4% | 0.0% | 0.0 | 0.0% | -53.65% |
| Colinz Laboratories Ltd | ₹11 Cr | ₹81.63 | 23.0 | 1.1 | 0.0% | 0.0% | 0.0 | 0.0% | +41.97% |
| Shanmuga Hospital Ltd | ₹52 Cr | ₹36.25 | 13.5 | 1.2 | 15.4% | 0.0% | 0.0 | 0.0% | +8.76% |
| Astonea Labs Ltd | ₹187 Cr | ₹267.5 | 40.4 | 3.2 | 26.3% | 0.0% | 0.0 | 0.0% | +97.2% |
| Ganga Pharmaceuticals Ltd | ₹7 Cr | ₹12 | 109.1 | 0.9 | 0.0% | 0.0% | 0.0 | 0.0% | -18.92% |
| Aashka Hospitals Ltd | ₹172 Cr | ₹81.25 | 70.7 | 1.7 | 13.0% | 0.0% | 0.0 | 0.0% | -26.07% |
| Fredun Pharmaceuticals Ltd | ₹1,295 Cr | ₹2,538 | 33.8 | 7.1 | 29.4% | 0.0% | 0.0 | 3.0% | +255.66% |
| Asston Pharmaceuticals Ltd | ₹65 Cr | ₹83.5 | 26.6 | 1.4 | 40.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Rekvina Laboratories Ltd | ₹25 Cr | ₹34.3 | 0.0 | -31.6 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Chennai Meenakshi Multispeciality Hospital Ltd-$ | ₹28 Cr | ₹38.93 | 0.0 | -11.1 | 0.0% | 0.0% | 0.0 | 0.0% | +27.22% |
| Medico Intercontinental Ltd | ₹23 Cr | ₹29.5 | 0.0 | 0.5 | 16.7% | 0.0% | 0.0 | 0.0% | -25.34% |
| Aptus Pharma Ltd | ₹317 Cr | ₹231 | 59.5 | 5.4 | 71.4% | 0.0% | 0.0 | 0.0% | 0.00% |
| Fabino Enterprises Ltd | ₹4 Cr | ₹20.31 | 0.0 | 1.1 | 0.0% | 0.0% | 0.0 | 0.0% | -18.76% |
| Phaarmasia Ltd | ₹61 Cr | ₹99.23 | 3.4 | 5.7 | -50.0% | 0.0% | 0.0 | 0.0% | +259.53% |
| Achyut Healthcare Ltd | ₹119 Cr | ₹8.52 | 493.0 | 3.7 | 4.0% | 0.0% | 0.0 | 0.0% | +162.15% |
| Evoq Remedies Ltd | ₹8 Cr | ₹2.3 | 4.6 | 0.2 | 0.0% | 0.0% | 0.0 | 0.0% | -23.59% |
| Fortis Malar Hospitals Ltd | ₹101 Cr | ₹51.9 | 22.3 | 2.9 | 0.0% | 0.0% | 0.0 | 0.0% | -30.23% |
| Transgene Biotek Ltd | ₹24 Cr | ₹3.1 | 0.0 | 2.7 | 0.0% | 0.0% | 0.0 | 0.0% | -24.39% |
| Global Longlife Hospital and Research Ltd | ₹13 Cr | ₹10.7 | 0.0 | 0.5 | 0.0% | 0.0% | 0.0 | 0.0% | -65.71% |
| Astal Laboratories Ltd | ₹345 Cr | ₹88.6 | 11.5 | 2.0 | 42.9% | 0.0% | 0.0 | 0.0% | +2.17% |
| Dipna Pharmachem Ltd | ₹20 Cr | ₹5.78 | 8.7 | 0.3 | 3.7% | 0.0% | 0.0 | 0.0% | -68.15% |
| Desh Rakshak Aushdhalaya Ltd | ₹15 Cr | ₹32.59 | 35.7 | 1.1 | 0.0% | 0.0% | 0.0 | 0.0% | -19.43% |
| Maitri Enterprises Ltd | ₹17 Cr | ₹37.2 | 150.0 | 3.9 | 0.0% | 0.0% | 0.0 | 0.0% | +36.56% |
| Hannah Joseph Hospital Ltd | ₹170 Cr | ₹101 | 20.7 | 2.2 | 16.3% | 0.0% | 0.0 | 0.0% | 0.00% |
| Accretion Nutraveda Ltd | ₹197 Cr | ₹268.8 | 75.1 | 4.6 | 100.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Trident Lifeline Ltd | ₹303 Cr | ₹262.65 | 20.4 | 3.6 | 37.5% | 0.0% | 0.0 | 0.0% | +5.27% |
| Parmax Pharma Ltd | ₹12 Cr | ₹84.53 | 0.0 | 0.0 | 0.0% | 0.0% | 0.0 | 0.0% | +78.0% |
| Speciality Medicines Ltd | ₹237 Cr | ₹199.25 | 27.5 | 4.8 | 45.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Sanjivani Paranteral Ltd | ₹167 Cr | ₹152.5 | 20.7 | 3.8 | 0.0% | 0.0% | 0.0 | 37.0% | -29.45% |
| Genpharmasec Ltd | ₹64 Cr | ₹1.14 | 0.0 | 1.0 | 1.9% | 0.0% | 0.0 | 0.0% | -49.11% |
| Lactose India Ltd | ₹150 Cr | ₹103 | 30.9 | 2.4 | 12.8% | 0.0% | 0.0 | 0.0% | +1.53% |
| Gujarat Inject Kerala Ltd | ₹151 Cr | ₹134.3 | 171.7 | 13.7 | 6.7% | 0.0% | 0.0 | 0.0% | +566.17% |
| Gujarat Terce Laboratories Ltd | ₹28 Cr | ₹33.99 | 0.0 | 4.2 | -25.0% | 0.0% | 0.0 | 0.0% | -41.09% |
| Kabra Drugs Ltd | ₹59 Cr | ₹22.84 | 11.7 | 2.3 | -5.9% | 0.0% | 0.0 | 0.0% | +127.04% |
| One Global Service Provider Ltd | ₹872 Cr | ₹612.55 | 17.7 | 8.6 | 25.7% | 0.0% | 0.0 | 0.0% | +197.07% |
| CCME Global Ltd | ₹529 Cr | ₹118.7 | 0.0 | 13.0 | 80.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Smruthi Organics Ltd | ₹132 Cr | ₹117.65 | 28.7 | 1.8 | 5.8% | 0.0% | 0.0 | 130.0% | -13.37% |
| ANG Lifesciences India Ltd | ₹35 Cr | ₹32.63 | 0.0 | 0.6 | -22.6% | 0.0% | 0.0 | 0.0% | +21.53% |
| Panchsheel Organics Ltd | ₹168 Cr | ₹117.15 | 14.0 | 1.2 | 18.2% | 0.0% | 0.0 | 250.0% | -18.45% |
| Ishita Drugs & Industries Ltd | ₹23 Cr | ₹73.1 | 26.3 | 2.1 | 33.3% | 0.0% | 0.0 | 0.0% | -5.05% |
| Gennex Laboratories Ltd | ₹231 Cr | ₹10.25 | 13.0 | 1.1 | 22.8% | 0.0% | 0.0 | 0.0% | -20.36% |
| Family Care Hospitals Ltd | ₹18 Cr | ₹2.9 | 0.0 | 1.9 | -488.9% | 0.0% | 0.0 | 0.0% | -39.58% |
| Norris Medicines Ltd | ₹13 Cr | ₹16.23 | 0.0 | -0.8 | 0.0% | 0.0% | 0.0 | 0.0% | -12.32% |
| Unjha Formulations Ltd | ₹9 Cr | ₹19.99 | 8.6 | 2.1 | 0.0% | 0.0% | 0.0 | 0.0% | -13.12% |
| Asarfi Hospital Ltd | ₹384 Cr | ₹211.1 | 23.5 | 3.9 | 20.0% | 0.0% | 0.0 | 0.0% | +80.47% |
| Coral Laboratories Ltd | ₹163 Cr | ₹616 | 11.6 | 0.8 | 13.7% | 0.0% | 0.0 | 33.0% | -15.1% |
| Shree Ganesh Remedies Ltd | ₹739 Cr | ₹659 | 40.8 | 4.8 | 18.7% | 0.0% | 0.0 | 0.0% | -9.54% |
| Bacil Pharma Ltd | ₹82 Cr | ₹39.97 | 113.9 | 3.0 | 0.0% | 0.0% | 0.0 | 0.0% | -20.28% |
| KMC Speciality Hospitals (India) Ltd | ₹1,545 Cr | ₹129 | 42.3 | 8.5 | 12.7% | 0.0% | 0.0 | 0.0% | +87.88% |
| Shelter Pharma Ltd | ₹53 Cr | ₹29.05 | 5.9 | 0.6 | 23.3% | 0.0% | 0.0 | 110.0% | -26.73% |
| Sharma East India Hospitals & Medical Research Ltd | ₹33 Cr | ₹105.5 | 28.3 | 2.6 | 9.1% | 0.0% | 0.0 | 0.0% | +37.6% |
| Pharmaids Pharmaceuticals Ltd | ₹106 Cr | ₹34.9 | 0.0 | 2.1 | -137.5% | 0.0% | 0.0 | 0.0% | -49.41% |
| Adline Chem Lab Ltd | ₹8 Cr | ₹13.7 | 0.0 | 0.0 | 0.0% | 0.0% | 0.0 | 0.0% | -4.93% |
| Beryl Drugs Ltd | ₹11 Cr | ₹20.73 | 705.0 | 1.0 | 11.1% | 0.0% | 0.0 | 0.0% | +8.82% |
| Shukra Pharmaceuticals Ltd | ₹1,375 Cr | ₹33.32 | 62.8 | 22.7 | 17.2% | 0.0% | 0.0 | 3.0% | +131.87% |
| Oxygenta Pharmaceutical Ltd | ₹205 Cr | ₹48.89 | 0.0 | -5.6 | 0.0% | 0.0% | 0.0 | 0.0% | -45.71% |
| Welcure Drugs & Pharmaceuticals Ltd | ₹36 Cr | ₹0.26 | 1.3 | 0.3 | 1.8% | 0.0% | 0.0 | 0.0% | -74.62% |
| Bharat Immunologicals & Biologicals Corporation Ltd-$ | ₹75 Cr | ₹16.85 | 0.0 | 1.0 | 0.0% | 0.0% | 0.0 | 0.0% | -37.91% |
| KK Shah Hospitals Ltd | ₹29 Cr | ₹40 | 0.0 | 2.2 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Sandu Pharmaceuticals Ltd | ₹37 Cr | ₹41.92 | 18.2 | 0.9 | 10.0% | 0.0% | 0.0 | 208.0% | -25.29% |
| Looks Health Services Ltd | ₹6 Cr | ₹8.31 | 30.0 | 0.3 | 0.0% | 0.0% | 0.0 | 0.0% | +77.19% |
| Vista Pharmaceuticals Ltd | ₹45 Cr | ₹7 | 0.0 | 1.0 | 0.0% | 0.0% | 0.0 | 0.0% | -36.36% |
| Titan Biotech Ltd | ₹1,871 Cr | ₹408.55 | 68.9 | 11.2 | 15.3% | 0.0% | 0.0 | 9.0% | +346.99% |
| Jenburkt Pharmaceuticals Ltd | ₹529 Cr | ₹1,112.85 | 16.3 | 2.9 | 19.3% | 0.0% | 0.0 | 168.0% | -1.67% |
| Bharat Parenterals Ltd | ₹863 Cr | ₹1,399.8 | 0.0 | 2.0 | -7.1% | 0.0% | 0.0 | 8.0% | +27.84% |
| Zenotech Laboratories Ltd | ₹275 Cr | ₹46.29 | 0.0 | 2.8 | 0.0% | 0.0% | 0.0 | 0.0% | -26.68% |
| Hindustan Bio Sciences Ltd | ₹9 Cr | ₹7 | 59.1 | 10.1 | 0.0% | 0.0% | 0.0 | 0.0% | -12.94% |
| Parnax Lab Ltd | ₹186 Cr | ₹136.35 | 14.8 | 2.1 | 18.2% | 0.0% | 0.0 | 0.0% | +43.68% |
| Decipher Labs Ltd | ₹8 Cr | ₹6.89 | 0.0 | 0.4 | -38.5% | 0.0% | 0.0 | 0.0% | -44.26% |
| Emmessar Biotech & Nutrition Ltd | ₹13 Cr | ₹25.62 | 40.1 | 10.8 | 0.0% | 0.0% | 0.0 | 0.0% | -25.74% |
| Everest Organics Ltd | ₹251 Cr | ₹275 | 49.0 | 3.5 | -2.4% | 0.0% | 0.0 | 0.0% | -34.56% |
| BDH Industries Ltd | ₹214 Cr | ₹514.65 | 20.5 | 3.0 | 17.3% | 0.0% | 0.0 | 121.0% | +89.21% |
| Novelix Pharmaceuticals Ltd | ₹112 Cr | ₹80.65 | 47.1 | 3.0 | 0.0% | 0.0% | 0.0 | 0.0% | +233.95% |
| Royal Sense Ltd | ₹75 Cr | ₹100 | 11.8 | 2.1 | 46.2% | 0.0% | 0.0 | 0.0% | -52.38% |
| Sunil Healthcare Ltd | ₹65 Cr | ₹67.7 | 22.8 | 1.0 | -2.0% | 0.0% | 0.0 | 0.0% | -6.61% |
| Denis Chem Lab Ltd | ₹100 Cr | ₹74 | 11.5 | 0.0 | 15.1% | 0.0% | 0.0 | 208.0% | -29.59% |
| Broach Lifecare Hospital Ltd | ₹10 Cr | ₹15.98 | 20.8 | 0.5 | 14.3% | 0.0% | 0.0 | 0.0% | 0.00% |
| Deccan Health Care Ltd | ₹31 Cr | ₹13.49 | 13.8 | 0.3 | 3.0% | 0.0% | 0.0 | 0.0% | -31.49% |
| Jeevan Scientific Technology Ltd | ₹167 Cr | ₹80 | 0.0 | 2.8 | 0.0% | 0.0% | 0.0 | 0.0% | +88.28% |
| Nexus Surgical And Medicare Ltd | ₹12 Cr | ₹20.26 | 20.5 | 8.6 | 0.0% | 0.0% | 0.0 | 0.0% | +17.45% |
| Mercury Laboratories Ltd | ₹91 Cr | ₹790 | 19.3 | 1.6 | 30.0% | 0.0% | 0.0 | 46.0% | -3.55% |
| Concord Drugs Ltd | ₹107 Cr | ₹76.97 | 184.1 | 2.4 | 0.0% | 0.0% | 0.0 | 0.0% | +138.08% |
| Star Source Multi Trade Ltd | ₹17 Cr | ₹85.65 | 0.0 | 12.1 | 0.0% | 0.0% | 0.0 | 0.0% | -33.45% |
| Cian Healthcare Ltd | ₹1 Cr | ₹8.26 | 0.0 | 0.0 | -104.0% | 0.0% | 0.0 | 0.0% | -84.04% |
| Genomic Valley Biotech Ltd | ₹8 Cr | ₹28.03 | 0.0 | 2.1 | 0.0% | 0.0% | 0.0 | 0.0% | -52.69% |
| Valencia Nutrition Ltd | ₹121 Cr | ₹57 | 34.7 | 3.2 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Chandra Bhagat Pharma Ltd | ₹25 Cr | ₹42.7 | 39.8 | 0.8 | 4.8% | 0.0% | 0.0 | 0.0% | 0.00% |
| Vivanza Biosciences Ltd | ₹8 Cr | ₹2 | 0.0 | 1.7 | -25.0% | 0.0% | 0.0 | 0.0% | -25.65% |
| Tyche Industries Ltd | ₹139 Cr | ₹128 | 20.3 | 1.0 | 9.3% | 0.0% | 0.0 | 222.0% | -13.1% |
| Kerala Ayurveda Ltd | ₹268 Cr | ₹185 | 0.0 | 33.1 | -116.7% | 0.0% | 0.0 | 0.0% | -57.38% |
| Brawn Biotech Ltd | ₹6 Cr | ₹20.5 | 0.0 | 1.7 | -200.0% | 0.0% | 0.0 | 0.0% | +18.91% |
| Auro Laboratories Ltd | ₹167 Cr | ₹258.7 | 51.5 | 3.8 | 4.8% | 0.0% | 0.0 | 0.0% | +0.51% |
| Kimia Biosciences Ltd | ₹169 Cr | ₹32 | 0.0 | 14.9 | 0.0% | 0.0% | 311.5 | 0.0% | -20.99% |
| Godavari Drugs Ltd | ₹130 Cr | ₹123.5 | 0.0 | 2.1 | 12.5% | 0.0% | 0.0 | 0.0% | +29.17% |
| Vikram Thermo India Ltd | ₹477 Cr | ₹235.5 | 14.0 | 3.5 | 7.1% | 0.0% | 0.0 | 66.0% | +28.65% |
| Zenith Healthcare Ltd | ₹16 Cr | ₹3.08 | 38.1 | 2.2 | 0.0% | 0.0% | 0.0 | 0.0% | -33.04% |
| Zenlabs Ethica Ltd | ₹19 Cr | ₹33.98 | 0.0 | 1.7 | 0.0% | 0.0% | 0.0 | 0.0% | +6.82% |
| Makers Laboratories Ltd | ₹94 Cr | ₹146 | 77.7 | 1.3 | 18.4% | 0.0% | 0.0 | 0.0% | -9.77% |
| NG Industries Ltd-$ | ₹42 Cr | ₹115 | 0.0 | 1.1 | 22.9% | 0.0% | 0.0 | 277.0% | -27.65% |
| Venmax Drugs and Pharmaceuticals Ltd | ₹29 Cr | ₹18.99 | 15.5 | 1.7 | 0.0% | 0.0% | 0.0 | 0.0% | -26.02% |
| Dhanvantri Jeevan Rekha Ltd | ₹8 Cr | ₹26.45 | 65.1 | 0.8 | 10.0% | 0.0% | 0.0 | 0.0% | +11.13% |
| Shamrock Industrial Company Ltd | ₹12 Cr | ₹23.56 | 0.0 | 10.5 | 0.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Soni Medicare Ltd | ₹31 Cr | ₹70.2 | 0.0 | 354.4 | 0.0% | 0.0% | 0.0 | 0.0% | +4.81% |
| Kobo Biotech Ltd-$ | ₹6 Cr | ₹8.12 | 0.0 | -0.1 | -20.8% | 0.0% | 0.0 | 0.0% | +157.78% |
| Advik Laboratories Ltd | ₹3 Cr | ₹1.81 | 0.0 | 4.9 | -100.0% | 0.0% | 0.0 | 0.0% | 0.00% |
| Avi Products India Ltd | ₹15 Cr | ₹47.54 | 0.0 | 2.4 | 0.0% | 0.0% | 0.0 | 0.0% | +82.85% |
| Bijoy Hans Ltd | ₹278 Cr | ₹70.46 | 0.0 | 0.0 | 0.0% | 0.0% | 0.0 | 0.0% | +206.35% |
| Dhruv Wellness Ltd | ₹5 Cr | ₹4.58 | 0.0 | -0.3 | 0.0% | 0.0% | 0.0 | 0.0% | -22.24% |
India is the pharmacy of the world, supplying 20% of global generic medicine volume. The sector is bifurcated — domestic formulations offer stable growth (10-12%) with high margins, while US generics face pricing erosion but massive volume opportunity. CDMO (Contract Development and Manufacturing) has emerged as a structural growth driver post-COVID.
Key focus areas: domestic chronic therapy mix, specialty pipeline in US, Biosimilar approvals, and FDA compliance track record. Margins vary widely — specialty players earn 25-30% EBITDA margins vs. commodity generics at 12-18%.
Zero or low debt is common, making the sector defensive. Valuations are elevated at 30-40x PE for quality names.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.